INHIBITORY EFFECTS OF ANTIHYPERTENSIVE DRUGS ON MESANGIAL CELL-PROLIFERATION AFTER ANTI-THYMOCYTE SERUM (ATS)-INDUCED MESANGIOLYSIS IN SPONTANEOUSLY HYPERTENSIVE RATS

Citation
S. Kiyama et al., INHIBITORY EFFECTS OF ANTIHYPERTENSIVE DRUGS ON MESANGIAL CELL-PROLIFERATION AFTER ANTI-THYMOCYTE SERUM (ATS)-INDUCED MESANGIOLYSIS IN SPONTANEOUSLY HYPERTENSIVE RATS, Life sciences, 54(24), 1994, pp. 1891-1900
Citations number
28
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Journal title
ISSN journal
00243205
Volume
54
Issue
24
Year of publication
1994
Pages
1891 - 1900
Database
ISI
SICI code
0024-3205(1994)54:24<1891:IEOADO>2.0.ZU;2-9
Abstract
The effects of antihypertensive drugs on mesangial cell proliferation were studied in spontaneously hypertensive rats (SHR) with anti-thymoc yte serum (ATS)-induced glomerulo-nephritis. Rats were treated with ei ther enalapril (Group 1), nifedipine (Group 2), or reserpine + hydroch lorothiazide + hydralazine (Group 3), or were untreated (Group 4). The animals were sacrificed 2, 4 and 7 days after ATS injection and the g lomerular cell number and degree of mesangial area expansion were exam ined. A marked, similar decrease in glomerular nuclear cell number (NC ) due to severe mesangiolysis was observed in all of the groups on day 2. Thereafter, an increase in NC reflecting mesangial cell proliferat ion after mesangiolysis occurred in Group 4 on days 4 and 7. In groups 1 and 2, the NC was significantly smaller than that in Group 4 on day s 4 and 7, indicating suppression of mesangial cell proliferation. In Group 3, however, the number of NCs did not differ from that in Group 4 on days 4 and 7, indicating a lack of such suppression by convention al antihypertensive drugs. The degree of mesangial area expansion (MS) showed the same pattern as mesangial cell proliferation. That is, the rapid increases in MS seen in Group 4 on days 4 and 7 were apparently suppressed in Groups 1 and 2, but not in Group 3. Our in vivo observa tions that both an angiotensin converting enzyme (ACE) inhibitor and a calcium channel blocker suppress mesangial cell proliferation and mes angial area expansion suggest that these agents have practical implica tions in the treatment of mesangial proliferative glomerular diseases through the suppression of excess mesangial cell proliferation.